C
Cumberland Pharmaceuticals Inc (CPIX)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
$5.21
-0.67 (-11.39%)
Market Cap: $88.16M
Last updated: Nov 17, 2026 at 11:03 AM ET
Cumberland Pharmaceuticals Inc (CPIX) Valuation Multiples
Cumberland Pharmaceuticals (CPIX) trades at 3.1x sales and 1.1x book value. Its P/S of 3.1x is above its 5-year median of 0.9x. Its forward P/E is 50.0x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 50.0x |
| Price to sales | 3.1x |
| Price to book | 1.1x |
| PEG | N/A |
Historical Medians
Against its 10-year medians, its P/S is 93.8% above 1.6x and its P/B is 15.4% below 1.3x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 3.1x | 0.9x | 1.6x |
| P/B | 1.1x | 1.0x | 1.3x |
Valuation History
Over the 10 year ends shown, its P/S ranged from 0.6x in 2023 to 3.2x in 2018.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $3.98 | N/A | 2.3x | 2.4x |
| 2024 | $2.37 | N/A | 0.9x | 1.4x |
| 2023 | $1.79 | N/A | 0.6x | 0.9x |
| 2022 | $2.25 | N/A | 0.8x | 0.9x |
| 2021 | $4.67 | N/A | 1.9x | 1.6x |
| 2020 | $2.95 | 24.6x | 1.2x | 0.9x |
| 2019 | $5.15 | 16.6x | 2.3x | 1.5x |
| 2018 | $6.03 | N/A | 3.2x | 1.7x |
| 2017 | $7.36 | N/A | 2.8x | 1.8x |
| 2016 | $5.50 | N/A | 2.7x | 1.2x |
Frequently Asked Questions About CPIX
What is CPIX's forward P/E ratio?
Cumberland Pharmaceuticals has a forward P/E ratio of 50.0x.
What is CPIX's price to sales ratio?
Cumberland Pharmaceuticals has a price to sales ratio of 3.1x.
CPIX pages: Overview, Earnings, Financials, Valuation, Competitors